59results about How to "Improve metabolic disorders" patented technology

An amino acid composition with high nutrition supporting effect is composed of acetylcysteine, acetyltyrosine and tryptophan in weight ratio of (0.81-2): (0.81-2): (0.9-1.6).

The invention relates to the field of liquid milk, in particular relating to a fermented milk beverage containing peanut, lotus root and pawpaw and a production method thereof. On the basis of 100 parts of fermented milk beverage by weight, the fermented milk beverage containing peanut, lotus root and pawpaw comprises: 30-80 parts of liquid milk by weight, 0.004-0.007 part of leaven by weight, 3.5-8.0 parts of sweet substance by weight, 0.2-0.7 part of acidity regulator by weight, 0.1-1.5 parts of stabilizing agent by weight, 1-30 parts of peanut paste by weight, 1-10 parts of lotus root powder by weight, 1-5 parts of pawpaw primary paste by weight and the balance water, wherein the stabilizing agent is composed of thickening agent and/ or emulsifier, and the thickening agent contains 0.1-0.25 part of high acyl pectin and propylene glycol alginate. The product of the invention has refreshing and smooth taste when being drunk and contains special fragrance of peanut, lotus root and pawpaw products. Tests prove that the product has no layering phenomenon or severe fat flotation in the storage and placement process within the 6-month quality guarantee period. Thus, the product of theinvention has favorable stability.

The present invention discloses a high-protein and full-nutrition formula powder and a preparation method thereof, and relates to the technical fields of medicines, special medical food and health-care food. The high-protein and full-nutrition formula powder comprises the following components: protein powder, vegetable oil, carbohydrates, inulin, oligofructose, soybean dietary fibers, compound vitamins and compound minerals. The full-nutrition formula food has the most significant characteristics that product cost is low, so that price is within a range acceptable to average consumers, and besides, the full-nutrition formula food can satisfy special needs for nutrients or meals by populations with limited eating, digestion and absorption disorders, metabolic disorders or specific disease states.

The invention discloses an application of honokiol in pharmacy, and a medicine used for treating type II diabetes mellitus. The invention provides an application of honokiol in preparing medicines used for treating type II diabetes mellitus, obesity caused by lipid metabolism disorder, or diseases related to insulin resistance. Honokiol is a PPAR alpha/gamma dual agonist. Therefore, honokiol can be used for ameliorating insulin resistance and reducing blood sugar, and honokiol can also be used for ameliorating lipid metabolism disorder and reducing weight.

The invention discloses a composite amino acid vitamin injection and the application thereof. Every 1000ml of the composite amino acid vitamin injection comprises 5-40g of L-leucine, 2-30g of L-isoleucine, 2-30g of L-valine, 5-90g of L-alanyl-L-glutamine, 1-5g of L-threonin 1-10g of L-lysine, 1-12g of L-methionine, 1-10g of L-phenylalanine, 0.5-8g of L-tryptophan, 2-30g of L-arginine, 1-10g of L-histidine, 1-100mg of vitamin B6, 0-50mg of vitamin B1 and 0-100mu g of vitamin B12. Aiming at variation of stress, immunity, metabolism and the like of a human body in a perioperative anesthesia period, the composite amino acid vitamin injection achieves the purposes of inhibiting catabolism, promoting anabolism, generating heat and keeping warm, improving body substance energy metabolism and immunity functions and accelerating heal through creative formulae on the basis of enhanced recovery after surgery.

The present invention relates to a kind of anti-senility plaster. Magnetic powder, rhodiola root, corydalis tuber, cassia, asarum herb, Kansui, licorice, musk, borneol and ginger juice in certain proportion are prepared into the plaster; and the plaster is adhered to corresponding acupoint. The plaster can eliminate free radical, lower the lipid peroxide level and strengthen SOD activity and total antioxidant capacity, and has the effects of warming and dredging meridian, promoting blood circulation to disperse blood clots, invigorating spleen and kidney, regining, resisting senility, etc. Needing no oral taking, the plaster has reduced liver burden, no toxic side effect, convenient use a fast acting.

The invention relates to a traditional Chinese medicine composite as well as a product and an application of the traditional Chinese medicine composite. The composite comprises the following traditional Chinese medicine raw materials in parts by weight: 20-40 parts of Astragalus mongholicus and 10-20 parts of mulberry and also comprises one or several of the following traditional Chinese medicine raw materials in parts by weight: 5-15 parts of salviae miltiorrhizae, 5-15 parts of angelica sinensis, 10-20 parts of processed fleece-flower root, 5-15 parts of rhizoma chuanxiong and 1-5 parts of pseudo-ginseng. The traditional Chinese medicine composite has better actions on lowering sugar, lowering fat, improving a blood rheology index, reducing urine protein or improving the creatinine clearance rate and especially has the actions on protecting the vascular endothelial cell, alleviating the damage degree of the endarterium and the like, and therefore the traditional Chinese medicine composite can be prepared into oral administration or external application products used for treating or controlling renal damage, neuropathy around limbs, high blood fat, impotence, prostatic hyperplasia, diabetes mellitus and complications, such as diabetic foot, diabetic nephropathy and diabetic retinal inflammation, and has good protecting action on the liver, the kidney, the pancreas and the intestinal mucosa.

The invention discloses bifidobacterium longum for relieving insulin resistance and application of the bifidobacterium longum, and belongs to the technical field of microorganisms. The bifidobacterium longum NSP008 disclosed by the invention can be used for inhibiting the increase of the body weight and the body fat of an insulin-resistant mouse on the premise of not influencing the food intake; the glucose tolerance of an insulin-resistant mouse is improved, and meanwhile, the blood sugar, serum insulin and an insulin resistance index of the mouse are reduced; the insulin-resistant mouse liver triglyceride and inflammation level can be adjusted, and liver tissue damage can be relieved; the intestinal flora structure is improved, and the growth of intestinal probiotics is promoted. The bifidobacterium longum NSP008 disclosed by the invention is used for preparing a pharmaceutical composition and fermented food for relieving insulin resistance, and has a very wide application prospect.

The invention discloses golden camellia honey. The golden camellia honey is prepared from the following materials in parts by weight: 30-45 parts of a golden camellia concentrated solution, 1-5 parts of water soluble pearl powder, 5-8 parts of yam flour, and 5-10 parts of oligosaccharide, wherein the golden camellia concentrated solution adopts an aqueous solution containing dry substances with a mass fraction of 30-70%; the dry substances comprise golden camellia, honeysuckle, calendula officinalis, taraxacum and honey; the mass fraction ratio of the dry substances is 12:(1-3): (2-4):(1-4):(4-8) in sequence. Compared with the conventional golden camellia drink, the golden camellia honey disclosed by the invention has the functions of clearing away heat and toxic materials and relieving inflammation, can obviously solve the problems of appetite, sleepness, stagnation of liver Qi and chest distress. The invention further discloses a preparation method for the golden camellia honey, and the method comprises the steps of cleaning, drying, impregnating and concentrating; the method is simple, and can increase the dissolving-out amount of health protection components in the golden camellia honey to the largest extent.

The invention discloses a lucid ganoderma compound skin care product and a preparation method thereof, and belongs to the technical field of cosmetics. The lucid ganoderma essence comprises a lucid ganoderma extract, rose hydrolat, EDTA-2Na, phenoxyethanol, essence and deionized water. By adjusting the mass percentages of the components and controlling the conditions such as temperature and time in the preparation method, the effect of the skin care product is enhanced, the skin care product has good skin care effects of whitening, moisturizing, resisting aging and resisting oxidation, formation and precipitation of melanin in the skin can be inhibited, stains can be removed, damage of ultraviolet rays to the skin can be reduced, epidermal and cells can be activated. The optical damage skin can be repaired, skin regeneration is accelerated, wrinkles are eliminated and removed, the skin elasticity is recovered, and the skin is enabled to be moist, fine and smooth.

The invention relates to the technical field of additives for livestock and in particular relates to a composition for preventing and treating bovine rumen acidosis and a preparation method of the composition. The composition comprises the following raw materials in parts by weight: golden camellia, folium isatidis, dandelion, purslane, poria cocos, fructus amomi, white paeony root, radix ophiopogonis, ephedra, puerarin, cinnamon, patrinia, rhizoma phragmitis, rehmannia, aloe, semen cuscutae, moutan bark, albumen powder and saccharomyces cerevisiae. The composition disclosed by the invention has an obvious effect of preventing and treating bovine rumen acidosis and can effectively reduce the incidence rate of the bovine rumen acidosis to 2.3-2.6%; due to a reasonable ratio, the Chinese herbal medicines can achieve excellent synergistic effects, the rumen pH value is effectively regulated, a balance of the rumen biota system is maintained, the bovine rumen acidosis is prevented to the greatest degree, and the composition achieves extremely important significances for improving the cattle production performance, reducing economic losses and promoting sustainable and healthy development of the cattle breeding industry.

The invention relates to low-GI total-nutrient meal replacement powder for intervening polycystic ovarian syndrome based on a ketogenesis principle and application of the low-GI total-nutrient meal replacement powder. The meal replacement powder is prepared from the following raw materials: freshly squeezed coconut oil, conjugated linoleic acid glyceride, linseed oil, olive oil, fish oil, high oleic acid sunflower seed oil, soybean oil, whey protein concentrate, soy isolate protein, hydrolyzed fish collagen, casein, rice protein, quinoa flour, chia seeds, konjac powder, inulin, fructo-oligosaccharide, L-carnitine, glutamine, enzymes, vitamin complex and mineral complex. The formula has the advantages that the energy supply ratio of the three nutrients is as follows: 70%-75% of fat, 3%-5% of carbohydrate and 20%-27% of protein. By utilizing the characteristics that MCT (medium-chain fatty acid) does not store fat and can quickly supply energy to a human body, insulin resistance is reduced, glycolipid metabolism disorder is improved, and the purpose of reducing weight is achieved. A scientific and convenient ketogenic diet replacement scheme is provided, and the ketogenic diet replacement scheme is convenient to implement and popularize in crowds.

The invention discloses plateau opuntia ficus-indica lozenges. The plateau opuntia ficus-indica lozenges are green and nutritional dietary foods which are developed and refined by using edible and medicinal plant raw materials, including natural opuntia ficus-indica which grows in 1800-meter high mountains, plateau jerusalem artichoke, chicory and so on; and the plateau opuntia ficus-indica lozenges are rich in plant polysaccharide compounds. The plateau opuntia ficus-indica lozenges have enhanced and improved nourishing diet health-care effects to the patients with the type-II diabetes, and are beneficial for improving healthy living standards of the diabetic patients. The plateau opuntia ficus-indica lozenges are prepared from the following raw materials: 40-50 parts of plateau opuntia ficus-indica, 15-20 parts of jerusalem artichoke, 10-15 parts of chicory, 8-12 parts of kudzu-vine roots, 5-10 parts of stevia rebaudiana bertoni and 2-3 parts of liquorice roots. The synergistic reactions of the plateau opuntia ficus-indica and the Chinese herbal medicines are utilized so as to effectively improve the nourishing and health-caring functions of the lozenges. Moreover, the prepared plateau opuntia ficus-indica lozenges are safe, free of side effects and convenient to eat, and have relatively good market application prospects.

The invention discloses a traditional Chinese medicine decoction for treating gout, which is prepared by the following raw materials: 10 to 20 grams of phellodendron, 15 to 25 grams of arisaema cum bile, 15 to 25 grams of tortoise plastron, 5 to 15 grams of clematis root, 5 to 15 grams of notopterygium root, 5 to 15 grams of Chinese atractylodes, 5 to 15 grams of tangerine peel, 5 to 15 grams of peonies and 3 to 8 grams of liquorice. The traditional Chinese medicine decoction for treating gout treats gout on the basis of clearing away heat, dispelling wind, nourishing liver and invigorating kidney, can relieve medicine effect decrease due to long-term western medicine taking or the toxic-side effects of severe adverse reactions, increase human immunity by regulating and strengthening the functions of human livers and kidneys, promote blood circulation to remove blood stasis, clear and activate channels and collaterals, and balance Yin and Yang, thereby achieving the aim of fundamentally and really curing gout.

The invention belongs to the field of medical and health care, and specifically provides a clinical nutrient for liver diseases. The liver disease clinical nutrient includes protein energy supply components, fat energy supply components and sugar energy supply components, and the energy supply ratio of the three is 17-20:18.5-20:60-64.5. At the same time, the present invention also provides the application of the liver disease clinical nutritional agent of the present invention in the preparation of a composition for treating liver diseases. The beneficial effect achieved is that the clinical nutritional agent for liver disease of the present invention can provide a pretreatment nutritional substrate that meets the special needs of liver disease through targeted nutritional formula adjustment. Reduce the burden on the liver, improve metabolic disorders, protect the existing liver function, and benefit the regeneration of liver cells. Then it can meet the continuous medium and high consumption energy demand of patients with chronic liver disease for long-term treatment, and provide the necessary and key nutritional guarantee for the reconstruction and long-term maintenance of liver-intestinal function.

The invention belongs to the field of medicines, and particularly relates to a Lam's diabetes treatment formula. The Lam's diabetes treatment formula is prepared from the following raw materials in parts by weight: 10 to 50 parts of white peony roots, 10 to 50 parts of astragalus and 10 to 20 parts of radix liquiritiae. The Lam's diabetes treatment formula can achieve a relatively good diabetes treatment effect based on a traditional Chinese medicine composition of a simple formula; the simple formula which is easy and convenient to operate and high in diabetes treatment speed and does not have toxic and side effect after people take the medicine is supplied to people suffering from diabetes and high blood sugar or complications of diabetes and high blood sugar.

The invention discloses a medicine composition used for treating myocardial ischemia and a preparation method thereof. The medicine composition used for treating myocardial ischemia is prepared from, by weight, 1.2-3.5 parts of bishydroxycoumarin, 1.0-3.0 parts of beta-ecdysterone, 0.8-4.2 parts of betulin, 1.2-3.6 parts of myristic acid, 0.2-0.8 part of bergapten, 0.1-0.5 part of anti-thrombotic medicine, 0.1-0.2 part of naltrexone, 0.3-1.0 part of menthol, 1.2-2.0 parts of kaempferol-3-rhamnoglucoside, 0.5-2.0 parts of phycocyanobilin, 0.2-0.5 part of erythropoietin, 0.1-1.0 part of alginic acid, 0.1-0.6 part of panaxoside, 0.1-0.2 part of catechinic acid, 0.3-1.2 parts of timnodonic acid and 3.0-10 parts of Arab galactose. The medicine composition used for treating myocardial ischemia is safe, effective, easy to prepare and free of toxic or side effect, can lower myocardial oxygen consumption, relieve myocardial metabolic disorder and correct hemodynamics disorder, has the remarkable effect on treating myocardial ischemia, and has the practical application value clinically for treating or preventing myocardial ischemia.

A low-dosage injection of tanshinone IIA-sodium sulfonate for treating coronary heart disease, angina pectoris, myocardial infarction and ventricular premature contraction is prepared from the tanshinone IIA-sodium sulfonate through depositing in water, cold storage, ultrafiltration, adding additives in dark condition, pouring in containers in Na atmosphere, sterilizing and lamp examining.

The invention belongs to the field of health-care foods, and discloses functional selenium-enriched black tomato noodles for diabetes and a making method of the functional selenium-enriched black tomato noodles for diabetes. According to the noodles, astragalus polysaccharide, a ginkgo leaf extract and selenium-enriched black tomato functional components are added, so that the generation of lipidperoxides in liver of patients suffering from diabetes can be effectively reduced, the vitality of an antioxidase system is improved, restoration of the liver antioxidation ability of the patients suffering from diabetes is facilitated, and the functional selenium-enriched black tomato noodles have prevention and treatment effect on exceptional rising of serum triglyceride and serum cholesterol inbodies of the patients suffering from diabetes, and can increase the content of high-density lipoprotein cholesterol and low-density lipoprotein cholesterol in serum, so that the blood fat level of organisms can be normal, and the functional selenium-enriched black tomato noodles can prevent and treat lipid metabolism disorder caused by diabetes and have prevention and treatment effect on diabetic complications.

A perfusion of tanshinone IIA-sodium sulfonate for treating coronary heart disease, angina pectoris, myocardiac infarction and ventricular early heartbeat contains tanshinone IIA sodium sulfonate (0.002-0.16 Wt%), antioxidizing agent (0-20), solubilizer (0-20), osmosis pressure regulator (0.3-75) and the water for perfusion. Its preparing process is also disclosed.

The invention provides a cicer arietinum saponin microcapsule as well as a preparation method and application thereof, and belongs to the field of microcapsule preparation in a natural product processing technology. Firstly, a wall material for preparing the microcapsule is provided, and components of the wall material comprise denatured cicer arietinum protein. The invention further provides thecicer arietinum saponin microcapsule prepared from the wall material. Under the specific preparation method disclosed by the invention, the total saponin in the cicer arietinum saponin extract is highin extraction rate and high in purity. The cicer arietinum saponin microcapsule prepared from the specific wall material is high in drug loading capacity and good in embedding effect. Besides, the cicer arietinum saponin microcapsule disclosed by the invention has good slow release and thermal stability. In addition, by improving in-vivo antioxidant enzyme activity of diabetic mice, the cicer arietinum saponin microcapsule can achieve the effects of relieving oxidative stress injury of tissues such as liver and pancreas, improving insulin resistance state and enhancing insulin sensitivity, the blood glucose level of the diabetic mice can be effectively reduced, lipid metabolism disorder of the mice can be improved, and the cicer arietinum saponin microcapsule has an excellent blood glucose lowering effect and a wide application prospect.

The invention discloses a traditional Chinese medicine for invigorating spleen and reinforcing healthy qi. The traditional Chinese medicine is prepared from the following medicinal materials in parts by weight: 15 parts of radix codonopsis, 15 parts of rhizoma atractylodis macrocephalae, 15 parts of poria cocos, 10 parts of radix astragali, 10 parts of rhizoma dioscoreae, 10 parts of tangerine peel, 10 parts of malt, 8 parts of common monkshood prepared daughter root, 5 parts of fruit of zollinger gromwell, 4 parts of delavay falsepanax herb and 6 parts of green tangerine peel. Preferably, the medicinal materials also include 12 parts of Chinese gall leaven and 5 parts of caulis spatholobi. Clinical experiments prove that the traditional Chinese medicine can be used for achieving a remarkable effect in invigorating spleen and reinforcing healthy qi by selecting proper medicinal materials and proportion, and especially has a more obvious effect in treating weakness of the spleen and stomach.

The invention, which belongs to the technical field of traditional Chinese medicines, discloses a traditional Chinese medicine suppository for treating chronic renal failure. The traditional Chinese medicine suppository comprises rheum officinale, the root of membranous milk vetch, rhizome of longspur epimedium, angelica sinensis, the root of red-rooted salvia, root of hairy asiabell, red flower,raw fossil fragments and concha ostreae, dandelion and glossy Ganoderma. The components are purified and then mixed with 10-30 parts of wheat starch and 5-15 parts of polyethylene glycol, the mixtureis heated to be molten, a thick paste product is added in batches, heating is performed continuously at the same temperature until mixing is full and uniform, the mixture is poured into a suppositorydie, and then cooling is performed and a finished product is taken out. The traditional Chinese medicine suppository disclosed by the invention is mainly used for treating chronic renal failure through anal administration and has the effects of improving the renal function of a patient with chronic renal failure and delaying deterioration of the renal function. The invention also provides a preparation process of the traditional Chinese medicine suppository.

The present invention relates to the technical field of livestock and poultry additives, particularly to a composition for preventing bovine rumen from food retention, and a preparation method thereof, wherein the raw materials comprise, by mass, camellia nitidissima, ophiopogon japonicus, fructus setariae germinatus, dioscorea opposita, perilla frutescens, chicken's gizzard membrane, frankincense, rhizoma corydalis, rhizoma imperatae, ligusticum chuanxiong hort, alisma orientalis, cyperus rotundus l, atractylodes macrocephala, and an auxiliary material. According to the present invention, the composition provides significant prevention and treatment effects for the food retention of bovine rumen, and can effectively reduce the incidence of bovine rumen food retention to 1.2-1.5%; and through the reasonable ratio of the Chinese herbs, the occurrence of the bovine rumen food retention is prevented at a maximum under the premise of no damage on the bovine gastrointestinal function, and the important significance is provided for the improvement of the bovine production performance, the reduction of economic losses, and the promotion of the sustained and healthy development of bovine breeding industry.

The invention relates to the field of health-care food, in particular to grease for preventing complications of cardiovascular diseases of diabetes mellitus, and the ratio of n-6 to n-3 PUFA of the grease is (4.5-5.5) 1. The grease can be applied to preparation of medicines for preventing complications of cardiovascular diseases of diabetes mellitus, or can be applied to preparation of health foodfor preventing complications of cardiovascular diseases of diabetes mellitus. As a diet, common symptoms of diabetic mice can be improved. Diet with the ratio of n-6 to n-3 PUFA being 4.5-5.5 1 increases the weight of diabetic mice, and the weight of the long-term intervention group and the weight of the intermittent intervention group are increased by 3.21% and 4.00% compared with a control group. As diet intervention, the composition can improve lipid metabolism disorder, reduce lipid deposition, significantly reduce AI and prevent diabetic cardiovascular disease complications.

The invention belongs to the technical field of natural medicines, and particularly relates to a triterpenoid saponin compound with an effect of improving glucose and lipid metabolism disorder as well as preparation and application of the triterpenoid saponin compound. The new triterpenoid saponin compound is separated from a Momordica charantia L. for the first time, research on a mouse primary hepatocyte model and a 3T3-L1 preadipocyte model finds that the new triterpenoid saponin compound has glycolipid metabolism regulating activity, and after the new triterpenoid saponin compound is matched with a known triterpenoid saponin compound Momordicoside G, ound is improved. the glycolipid metabolism regulating activity is obviously higher than that of a single compound under the same dosage, so that the novel triterpenoid saponin compound and the compound thereof can be used for improving the glycolipid metabolism disorder, and a new way is provided for treating diabetes mellitus.